EHRA Premium Access

Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Congress Presentation

About the speaker

Doctor William Mcintyre

McMaster University, Hamilton (Canada)
1 presentation
0 follower

5 more presentations in this session

Diabetes mellitus, time in the therapeutic range and adverse outcomes in patients with atrial fibrillation: insights from the AFFIRM study

Speaker: Doctor M. Proietti (Milan, IT)


Different obesity paradox of ischemic stroke without and with atrial fibrillation

Speaker: Assistant Professor Y. Baek (Incheon, KR)


Usefulness of CHADS2-VASc score in predicting stroke in patients with atrial fibrillation and heart failure with preserved ejection fraction

Speaker: Doctor A. Berkovitch (Ramat Gan, IL)


Prediction of Thromboembolic Events in Anticoagulated Patients with Atrial Fibrillation: Comparison of CHA2DS2-VASc and GARFIELD-AF Stroke Risk Scores

Speaker: Doctor M. Proietti (Milan, IT)


Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure

Speaker: Doctor S. Bordignon (Frankfurt, DE)


Access the full session

Moderated ePosters 11: AF: stroke and anticoagulation

Speakers: Doctor W. Mcintyre, Doctor M. Proietti, Assistant Professor Y. Baek, Doctor A. Berkovitch, Doctor M. Proietti...

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb